Skip to main content
FinSpry Logo
FinSpry
NVCR logo
NVCR
(NASDAQ)
NovoCure Limited
$15.63-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NovoCure Limited (NVCR) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for NovoCure Limited stock.

Analyst Consensus Rating

Investment consensus from 3 professional research analysts

Consensus Rating

Hold
Based on 3 unique analysts
(4 total ratings in last 90 days)
Low Confidence∞:1 Buy/Sell

Average Price Target

$27.00
↑ 72.74% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest NVCR Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Emily Bodnar
HC Wainwright
BuyMaintains
$46.00
Jessica Fye
JP Morgan
HoldMaintains
$17.00
Unknown Analyst
Wedbush
HoldMaintains
$18.00
Emily Bodnar
HC Wainwright
BuyMaintains
$46.00

Frequently Asked Questions

What is the analyst consensus rating for NVCR?

The analyst consensus rating for NVCR is "Hold" based on 3 analyst recommendations.

What is the average price target for NVCR?

The average 12-month price target for NVCR is $27.00, representing an upside of 72.7% from the current price of $15.63.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.